Ecolab Closes In on $5 Billion Deal for KKR's AI Cooling Star CoolIT
Ecolab nears $4.5–5B acquisition of CoolIT Systems from KKR, riding AI-driven demand for advanced data-center liquid cooling—up massively from 2023's $270M valuation.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Ecolab nears $4.5–5B acquisition of CoolIT Systems from KKR, riding AI-driven demand for advanced data-center liquid cooling—up massively from 2023's $270M valuation.
Iran's missile strikes cause extensive damage to Qatar's Ras Laffan LNG hub (20% of world supply). Prices soar, Europe & Asia brace for shortages through 2026.
Eli Lilly’s retatrutide delivered up to 2.0% A1C reduction and 16.8% weight loss (36.6 lbs) in its first Phase 3 trial for type 2 diabetes. Analysts call it a key growth driver for Lilly with strong results vs Mounjaro.
Fannie Mae and Freddie Mac shares hit 1-year lows in March, down ~70% in 6 months as investors doubt Trump administration's privatization plans and IPO timeline.
Canaccord Genuity starts coverage on MapLight Therapeutics (MPLT) with Buy rating and $35 price target.
Canadian Solar shares tank 27% after Q4 revenue miss ($1.22B vs. $1.35B expected), $86M loss, and soft Q1 outlook. CEO calls 2026 a transition year.